Clinical Trials Logo

Cholecystectomy clinical trials

View clinical trials related to Cholecystectomy.

Filter by:

NCT ID: NCT04270357 Completed - General Surgery Clinical Trials

Surgical Practices in Algeria : the Cholecystectomy

Start date: November 1, 2016
Phase:
Study type: Observational

An anonymous national survey involving all practicing Algerian surgeons was conducted. At the end of the survey, all data were captured and processed using the SPSS v20 software; χ 2 tests were used to compare different groups of surgeons.

NCT ID: NCT04089592 Completed - Cholecystectomy Clinical Trials

Comparison Of Dexmedetomidine and Fentanyl In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy.

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

Compare effects of intravenous dexmedetomidine and fentanyl in attenuation of intubation response in a patient undergoing laparoscopic cholecystectomy. Compare the effects of intravenous dexmedetomidine and fentanyl in sedation, perioperative complications, and recovery in these patients. Dexmedetomidine is comparatively a newer drug in countries like Pakistan. There is no research work available at the national level and scarcity of data at an international level with inconclusive outcomes. Our participation in the form of this research will add to scientific literature and step up ahead at the international level. Fentanyl citrate is a narcotic analgesic interacting predominantly with the opioid μ receptor and exerting its principal pharmacological effect on CNS. Its primary action of therapeutic value is analgesia and sedation. It is extensively used for anesthetic and analgesic most often in operating room and ICU.

NCT ID: NCT04033822 Active, not recruiting - Cholecystitis Clinical Trials

Fast Track Pathway to Accelerated Cholecystectomy

FAST
Start date: January 22, 2020
Phase: N/A
Study type: Interventional

More than 10% of Canadians have gallstones, and approximately 10% of these individuals will develop gallbladder inflammation related to gallstones, which is referred to as acute cholecystitis (AC). Patients with AC who do not have their gallbladder surgically removed have a 30% risk of serious complications that can lead to death. Surgery is the only definitive treatment for AC, however, there is controversy regarding the ideal timing of surgery. The two main approaches are early surgery (typically within 7 days of diagnosis) or delayed surgery (7 days to 6 weeks after diagnosis). Although preliminary evidence suggests that early surgery is associated with shorter hospital length of stay, lower risk for complications, and lower costs, practice varies widely regarding the timing of surgery. The limitations of the existing studies include small sample sizes, varied definitions of early versus delayed surgery, and an imbalance of risk between study groups. The proposed pilot study aims to inform the design of a large clinical trial that will compare the outcomes of patients with AC who receive accelerated surgery (i.e., as soon as possible with a goal of surgery within 6 hours of diagnosis) with those who receive standard care.

NCT ID: NCT03817541 Recruiting - Clinical trials for Bariatric Surgery Candidate

Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients

Start date: November 14, 2018
Phase: N/A
Study type: Interventional

Determination of accuracy With Edmond (reg) expiratory propofol measurement Device, compared With concommitant plasma samples of propofol

NCT ID: NCT03812432 Active, not recruiting - Cholecystectomy Clinical Trials

Cholecystocholangiography by Direct Intragallbladder Injection of ICG

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to visualize the bile ducts by injecting a contrast that is only visible with infrared light. For this, a quantity of bile will be extracted from the gallbladder by puncture and the same amount of contrast will be introduced. During the intervention teh tissue wil be exposure to infrared light to visualize the bile ducts. This technique aims to increase safety in surgery to avoid damaging bile or vascular structures during gallbladder interventions.

NCT ID: NCT03577873 Completed - Complication Clinical Trials

RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

To discuss necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.

NCT ID: NCT03510923 Completed - Cholecystectomy Clinical Trials

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy

FANCY
Start date: May 1, 2018
Phase:
Study type: Observational

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

NCT ID: NCT03437187 Completed - Cholecystectomy Clinical Trials

The Beneficial Effect of Quadratus Lumborum Block After Laparoscopic Cholecystectomy

Start date: January 20, 2018
Phase: N/A
Study type: Interventional

The enhanced recovery after surgery and laparoscopic approach is essential after day-case surgery. The patients want to go home early without pain and nausea, and the hospitals need the post-operative capacity for more patients. Many patients have pains, nausea and vomiting postoperatively. Postoperative pain is an expected but undesirable effect after an operation. The aim of the study is to find out if a bilateral quadratus lumborum block has a beneficial effect after a cholecystectomy.

NCT ID: NCT03402542 Completed - Cholecystectomy Clinical Trials

Eligibility Criteria for Cholecystectomy in Ambulatory Surgery

Start date: December 21, 2017
Phase:
Study type: Observational

Cold laparoscopic cholecystectomy is the gold standard for the management of symptomatic vesicular stones. There is considerable controversy as to whether it should be practiced in outpatient surgery or as part of inpatient surgery, regarding to patient safety. "Minor" surgical procedures, such as anal surgery or simple inguinal hernia interventions, were initially considered eligible for an outpatient procedure. Advances in surgical techniques, anesthesia and early rehabilitation have also made it possible to consider more "heavy" interventions, such as cholecystectomy. The aim of this study is to identify eligible patients for laparoscopic cholecystectomy in outpatient surgery, taking surgical criteria into account.

NCT ID: NCT03329859 Completed - Laparoscopy Clinical Trials

Microcomplications in Lap. Cholecystectomy: Reducing Intraoperative Interruptions by High Resolution Standardization

Start date: May 1, 2012
Phase: N/A
Study type: Interventional

Objective: Investigators aimed to evaluate the impact of a high resolution standardized laparoscopic (HRSL) cholecystectomy protocol on operative time and intraoperative interruptions in a teaching hospital. Background: Interruptions of the surgical workflow or microcomplications (MC) lead to prolonged procedure times and costs and can be indicative for surgical mistakes. Reducing MC can improve operating room efficiency and prevent intraoperative complications. Methods: Audio video records of laparoscopic cholecystectomies were reviewed regarding type, frequency and duration of MC before and after the implementation of a HRSL which included the introduction of a stepwise protocol for the procedure and a teaching video. After consent operating team members were obliged to prepare the operation with these resources.